A review of the acute subjective effects of MDMA/ecstasy
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Aim Although several relatively recent reviews have summarized the neuropsychiatric effects associated with chronic ecstasy use, there is no published comprehensive review of studies on the acute subjective effects (ASEs) of MDMA/ecstasy. Design The present study reviewed the prevalence, intensity and duration of ASEs collected from 24 studies that provided frequency data on the prevalence of self‐reported ecstasy effects and/or provided data on the intensity of ecstasy effects. Findings Although hundreds of ASEs have been reported following MDMA consumption, we identified a subset of effects reported repeatedly by meaningful proportions and large numbers of participants across multiple investigations, most of which were either emotional (e.g. anxiety, depression, closeness, fear, euphoria, calmness) or somatic (e.g. nausea/vomiting, bruxism, muscle aches/headache, sweating, numbness, body temperature changes, fatigue, dizziness, dry mouth, increased energy). Only one sexual ASE (sexual arousal/increased sensual awareness), one cognitive ASE (confused thought), one sensory–perceptual ASE (visual effects/changes in visual perception), one sleep‐related ASE (sleeplessness) and one appetite‐related ASE (decreased appetite) were reported across five or more investigations. Three factors—number of hours between ingestion and assessment, dose level, and gender—have been associated with the acute subjective experience of MDMA/ecstasy. Conclusions This review provides useful information for clinicians and researchers who want to understand the desirable and undesirable ASEs that may motivate and restrain ecstasy use, for public health advocates who seek to reduce biomedical harms (e.g. fainting, dehydration, shortness of breath, bruxism) associated with recreational use of MDMA/ecstasy, and for educators who wish to design credible prevention messages that neither underestimate nor exaggerate users’ experiences of this drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Stress, anxiety, and cognitive interference: reactions to tests
Sarason, I. G. (1984) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.46.4.929 · Cited by 959
The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Subjective Reports of the Effects of MDMA in a Clinical Setting
Greer, G., & Tolbert, R. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472364 · Cited by 413
Gender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360
Increasing MDMA use among college students: results of a national survey
Strote, J., Lee, J. E., & Wechsler, H. (2002) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00315-9 · Cited by 245
Camí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1131-1 · Cited by 229
Cited by
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06083-y · Cited by 88
“2014; Sessa 2017), as well as adverse subjective effects such as fearfulness, dysphoria, confusion, sleeplessness, and decreased appetite (Baylen and Rosenberg 2006).”
BackgroundParrott, A. C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0703-5 · Cited by 87
“Before 1987, there was little empirical evidence on the effects of MDMA in humans, but now, there is a far more extensive database ( Baylen and Rosenberg 2006; Dumont and Verkes 2006; Hegadoren et al. 1998; Parrott 2001, 2006).”
BackgroundInfluentialThe neuropsychology of ecstasy (MDMA) use: a quantitative review.
Zakzanis, K. K., Campbell, Z., & Jovanovski, D. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.873 · Cited by 87
MDMA decreases the effects of simulated social rejection
Frye, C. G., Wardle, M. C., Norman, G. J., & de Wit, H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.030 · Cited by 85
Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders
Harada, T., Tsutomi, H., Mori, R., & Wilson, D. B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011315.pub2 · Cited by 76
Metadata
- Authors
- Baylen, C. A., & Rosenberg, H.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2006-06-02
- Volume
- 101
- Issue
- 7
- Pages
- 933-947
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2026781905
- Cited by
- 211
- References
- 11
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of the acute subjective effects of MDMA/ecstasy. https://app.cochat.ai/papers/10.1111/j.1360-0443.2006.01423.x
- The paper
- Baylen, C. A., & Rosenberg, H. (2006). A review of the acute subjective effects of MDMA/ecstasy. Addiction. https://doi.org/10.1111/j.1360-0443.2006.01423.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.